[ad_1]
Mandaviya on Monday announced that India will resume export of surplus COVID-19 vaccines in the fourth quarter of 2021 under the ‘Vaccine Maitri’ programme and to meet its commitment to the COVAX global pool, but vaccinating its own citizens remains the topmost priority of the government.
India stopped the export of COVID-19 vaccines after the second wave of the pandemic hit the country in April this year.
Asserting that vaccination of its own citizens remains the government’s topmost priority, Mandaviya said, “India will be resuming the export of COVID-19 vaccines under Vaccine Maitri in order to fulfil the commitment of India towards COVAX in line with our motto of ”Vasudhaiva Kutumbakam”.
The cumulative doses administered so far across the country has crossed 82.65 crore.
COVAX is an initiative for equitable global access to COVID-19 vaccines. COVAX is co-led by Gavi, the Coalition for Epidemic Preparedness Innovations (CEPI) and the WHO.
[ad_2]
❤️ Support Independent Journalism
Your contribution keeps our reporting free, fearless, and accessible to everyone.
Or make a one-time donation
Secure via Razorpay • 12 monthly payments • Cancel anytime before next cycle


(We don't allow anyone to copy content. For Copyright or Use of Content related questions, visit here.)

The Chenab Times News Desk


